Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Radiotherapy in Advanced Head and Neck Cancer
NCT00004227Phase 3Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 1999
- Primary completion
- Mar 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of cetuximab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Alabama at Birmingham. Started Apr 1999; status: terminated.
02
Drugs
cetuximab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00004227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004227.